Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.
Acute Motor-dominant Polyneuropathy as Guillain-Barré Syndrome and Multiple Mononeuropathies in a Patient with Sjögren's Syndrome.
The functional performance status during weekdays and weekends in persons with multiple sclerosis.
A decade of natalizumab and PML: Has there been a tacit transfer of risk acceptance?
Static and dynamic functional connectivity in patients with chronic fatigue syndrome: use of arterial spin labelling fMRI.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
[Relationship between serum erythropoietin levels and brain injury in preterm infants].
Multifocal inflammatory demyelination in a patient with rheumatoid arthritis and treatment complications.
Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
Combined effects of transferrin and thyroid hormone during oligodendrogenesis In vitro.
High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis.
A new dawn for genetic association studies in multiple sclerosis.
Clinical characteristics of disabling attacks at onset in patients with neuromyelitis optica spectrum disorder.
Patchy white matter hyperintensity in ring chromosome 18 syndrome.
Special Issue: Myelin Repair.
Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol-induced kindling model.
Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments.
Drug-induced progressive multifocal leukoencephalopathy: a case/noncase study in the French pharmacovigilance database.
Central pontine myelinolysis caused by hypernatremia.
Scattering the spotlight on microparticles.
Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes.
Neuroleptic Malignant Syndrome Associated with Refractory Acute Disseminated Encephalomyelitis.
Leptin inhibitors from fungal endophytes (LIFEs): Will be novel therapeutic drugs for obesity and its associated immune mediated diseases.
Patient Management Problem.
The effect of electronic package on satisfaction in multiple sclerosis patients.
Pages
« first
‹ previous
…
817
818
819
820
821
822
823
824
825
…
next ›
last »